The United Laboratories International Holdings(HK:3933)
HK$7.76-0.13 (-1.59%)
HK:3933
The United Laboratories International Holdings financials statements
HK$7.76
At close:-0.13 (-1.59%)
Want to see HK:3933 full AI Analyst Report?
The United Laboratories International Holdings (3933) Financial Statements
7 Followers
The United Laboratories International Holdings Financial Overview
The United Laboratories International Holdings's market cap is currently ¥15.54B. The company's EPS TTM is ¥0.28; its P/E ratio is 23.74; and it has a dividend yield of 3.85%. The United Laboratories International Holdings is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is ¥0.23. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 13.21B | ¥ 13.76B | ¥ 13.74B | ¥ 11.33B | ¥ 9.70B |
| Gross Profit | ¥ 5.51B | ¥ 6.08B | ¥ 6.33B | ¥ 4.97B | ¥ 4.21B |
| Operating Income | ¥ 2.27B | ¥ 3.12B | ¥ 3.29B | ¥ 2.02B | ¥ 1.41B |
| EBITDA | ¥ 2.87B | ¥ 3.43B | ¥ 3.98B | ¥ 2.57B | ¥ 2.00B |
| Net Income | ¥ 2.09B | ¥ 2.66B | ¥ 2.70B | ¥ 1.58B | ¥ 988.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 11.24B | ¥ 6.33B | ¥ 4.26B | ¥ 4.74B | ¥ 3.33B |
| Total Assets | ¥ 30.91B | ¥ 25.83B | ¥ 21.02B | ¥ 18.98B | ¥ 16.33B |
| Total Debt | ¥ 4.99B | ¥ 3.16B | ¥ 1.50B | ¥ 2.46B | ¥ 1.84B |
| Net Debt | ¥ -6.25B | ¥ -3.17B | ¥ -2.76B | ¥ -2.28B | ¥ -1.49B |
| Total Liabilities | ¥ 13.34B | ¥ 11.40B | ¥ 8.27B | ¥ 8.37B | ¥ 6.99B |
| Stockholders' Equity | ¥ 17.40B | ¥ 14.39B | ¥ 12.73B | ¥ 10.61B | ¥ 9.34B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 855.45M | ¥ 1.33B | ¥ 977.50M | ¥ 1.25B | ¥ 1.06B |
| Operating Cash Flow | ¥ 3.75B | ¥ 3.20B | ¥ 2.44B | ¥ 2.03B | ¥ 1.54B |
| Investing Cash Flow | ¥ -2.17B | ¥ -1.73B | ¥ -1.56B | ¥ -594.92M | ¥ -587.22M |
| Financing Cash Flow | ¥ 2.78B | ¥ 596.91M | ¥ -1.36B | ¥ -24.17M | ¥ -620.93M |
Currency in CNY
